Antiviral Drug Discovery & Development Conference to Feature Big Pharma Advances in Respiratory/Influenza, HIV, & HBV/HCV in March, in Princeton, NJ
20.12.1999, 10:45
PRINCETON, N.J., USA (PROTEXT) - A major new, international
conference presenting the newest advances by the pharmaceutical
industry in developing novel drugs to fight viral diseases,
including respiratory/influenza, HIV, and hepatitis B & C, will
take place on March 15-16, 2000 at the Hyatt Regency Hotel in
Princeton, NJ, announces Strategic Research Institute.
The conference will feature new flu compounds targeting
neuraminidase inhibitors to be presented by Roche (Tamiflu),
Glaxo Wellcome (Relenza), and RW Johnson PRI (RWJ-270201);
Agouron's protease inhibitor for rhinovirus infection, and
clinical summary of ViroPharma's Pleconaril, a novel therapy for
picornaviral disease, will also be featured.
In HIV, the conferences focuses on Trimeris' fusion inhibitor,
T-20 and Merck's Integrase inhibitor; also featured will be new
work on reverse transcriptase inhibitors (BioChem Pharma and
DuPont), plus contribution from Glaxo Wellcome on resistance
testing as a guide to antiretroviral discovery and development in
light of the recent FDA Advisory Committee meeting.
The HBV/HCV section will feature discussion of Schering
Plough's Ribavirin, Roche's Pegainterferon alfa-2a and
contributions from Eli Lilly and Glaxo Wellcome; Emory University
and Novirio Pharmaceuticals will present new data on nucleoside
analogs and L-nucleosides, both having shown potent activity
against hepatitis B.
To request the agenda and/or register, please contact Camille
Coward of Strategic Research at ccoward@srinstitute.com (include
company/university and mailing address) or by phone at (USA) 212-
967-0095, ext 255; for information on sponsorship & exhibition
contact Mark Alexay at (USA) 212-967-0095, x251 or
malexay@hotmail.com . ots Original Text Service: Strategic
Research Institute L.P. Internet: http://www.newsaktuell.de
Contact: Camille Coward, (USA) 212-967-0095 ext. 255, or
ccoward@srinstitute.com, or Mark Alexay, Sponsorship and
Exhibition, (USA) 212-967-0095, ext. 251, or malexay@hotmail.com,
both of the Strategic Research Institute L.P. Web site:
http://www.srinstitute.com
Subscribers please note that material bearing the slug
"PROTEXT" is not part of CTK's news service and is not to be
published under the "CTK" slug. Protext is a commercial service
providing distribution of press releases from clients, who are
identified in the text of Protext reports and who bear full
responsibility for their contents.
PROTEXT